Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025
The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...
Taiwan News6h
ORIC® Pharmaceuticals Announces ORIC-944 Preclinical Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
ORIC-944 is a potent, highly selective, orally bioavailable, allosteric inhibitor of PRC2 that demonstrates best-in-class drug properties, including potency, solubility, and pharmacokinetics, with ...
Glam on MSN10h
Our Dermatologist Breaks Down How Your Body Hair Changes As You Get Older
We all know that our scalp hair grays and thins as we age, but did you know that your body hair experiences serious changes, ...
Stacker on MSN14h
Shampoos for treating hair loss: Pros, cons, and do they work?
As an "androgen" hormone, it plays an important part in male biological characteristics like muscle mass, the development of body hair, and deepness of voice. In men, DHT is created when an enzyme ...